Complete Regression of Anogenital Warts Following Intralesional Measles-Mumps-Rubella (MMR) Vaccine: A Case of Two.

INTRODUCTION

Anogenital warts (AGW) are benign proliferative lesions on the epithelium or mucosa caused by (HPV) types 6 and 11. HPV infection occurs when viral particles enter the basal cells through microtrauma in the epithelium. AGW demonstrate a predilection for involvement of any region of the genitalia, anal or perianal area, inguinal, pubic region, and is very common in the traumatized area during sexual intercourse. Immunotherapy is one of the therapeutic modalities for AGW. The measles, mumps, and rubella (MMR) vaccine given by intralesional injection can be a promising therapeutic option for multiple AGW, particularly those located hard to reach areas.

CASE PRESENTATION

We described two cases of anogenital wart type condyloma acuminata in a 19-year-old female and 21-year old female patient, who presented to Dermatology, Venereology, and Aesthetic Department. On physical examination, both cases have multiple skin-colored papules appeared with a verrucous surface in the labia majora and vagina. The patients received 0.5 mL of MMR vaccine, which was injected intralesional into the largest wart without a pre-sensitization test. The injections are planned to be administered every three weeks, with a maximum of three injections. The warts resolved completely and left no scars. The side effect when the injection is mild pain in the injection site.

CONCLUSION

Intralesional MMR vaccine can be considered one of the treatments for AGW because it has been proven safe and effective, but more research is needed as a therapy for AGW.